Journal of the neurological sciences · 2026
Transorbital sonography reveals retrobulbar optic nerve neuroaxonal changes in multiple sclerosis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Merli N, Ferri C, Copetti M, Inchingolo V, Malferrari G, Paciaroni M, Pugliatti M
Аннотация
BACKGROUND: The optic nerve (ON), as an extension of the central nervous system, reflects multiple sclerosis (MS) pathological processes. Transorbital sonography (TOS) is emerging as a novel technique to detect ON changes. Our aim was to investigate retrobulbar ON morphometric changes in MS and their relationship with prior history of optic neuritis.
METHODS: 122 MS subjects were enrolled, 68 with and 54 without history of optic neuritis. ON diameters without and with sheath were measured at 3 mm (OND3 and ONSD3) and 5 mm (ONSD5) posterior to the optic disc; myelination index (MI=ONSD3/ONSD5) was calculated. To account for intrasubject dependencies, linear mixed models (LMMs) for repeated measures were employed, adjusting for age at onset and body mass index.
RESULTS: ONs with history of inflammation (I-ON) exhibited significantly reduced diameters versus companion nerves in both measurements with and without sheath (OND3: p = 0.002; ONSD3: p = 0.010; ONSD5: p = 0.046). All ONs diameters progressively decreased with increasing neuritis frequency, demonstrating a dose-response effect. Significant measurement reductions in OND and ONSD3 were observed in I-ON of patients with Expanded Disability Status Scale >3, whereas no significant differences emerged for progression index (PI) > 0.20 among ONs with and without history of optic neuritis.
CONCLUSIONS: TOS reliably captures ON morphometric changes related to inflammatory history and chronic neuroaxonal injury in MS, supporting its role as a promising biomarker of disability burden and progression independent of relapse activity (PIRA).
METHODS: 122 MS subjects were enrolled, 68 with and 54 without history of optic neuritis. ON diameters without and with sheath were measured at 3 mm (OND3 and ONSD3) and 5 mm (ONSD5) posterior to the optic disc; myelination index (MI=ONSD3/ONSD5) was calculated. To account for intrasubject dependencies, linear mixed models (LMMs) for repeated measures were employed, adjusting for age at onset and body mass index.
RESULTS: ONs with history of inflammation (I-ON) exhibited significantly reduced diameters versus companion nerves in both measurements with and without sheath (OND3: p = 0.002; ONSD3: p = 0.010; ONSD5: p = 0.046). All ONs diameters progressively decreased with increasing neuritis frequency, demonstrating a dose-response effect. Significant measurement reductions in OND and ONSD3 were observed in I-ON of patients with Expanded Disability Status Scale >3, whereas no significant differences emerged for progression index (PI) > 0.20 among ONs with and without history of optic neuritis.
CONCLUSIONS: TOS reliably captures ON morphometric changes related to inflammatory history and chronic neuroaxonal injury in MS, supporting its role as a promising biomarker of disability burden and progression independent of relapse activity (PIRA).